Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Horst Meyer is active.

Publication


Featured researches published by Horst Meyer.


Naunyn-schmiedebergs Archives of Pharmacology | 1981

Effects of unsymmetrical ester substituted 1,4-dihydropyridine derivatives and their optical isomers on contraction of smooth muscle

Robertson Towart; Egbert Wehinger; Horst Meyer

SummaryThe optical isomers of two nifedipine-like 1,4-dihydropyridine derivates have been synthesised and tested in vitro. The (−)-isomer (S-configuration of both compounds) was more potent than the racemate, which in turn was more potent than the (+)-isomer (R-configuration). The S-configuration isomers are approximately ten times more potent than nifedipine, and may represent the optimal structure and configuration for binding to and inhibiting calcium channels.


Archive | 1978

QSAR-Studies in the Inotropic Action of Nifedipine-Derivatives

R. Rodenkirchen; E. Möller; R. Mannhold; F. Bossert; Horst Meyer

Among the so-called calcium-antagonists one of the most potent and commonly used compounds is nifedipine. Based on an analysis of the specific inotropic action of nifedipine exerted in cat papillary muscles we have investigated the physicochemical and steric requirements for this action. The quantitative structure-activity relationships (QSAR-studies) were realized by means of a Hansch analysis: Substituent constants, describing electronic, hydrophobic and steric properties of the nifedipine-derivatives were correlated with their biological activity (ED50-value for the negative inotropic effect). For a group of ortho-substistuted nifedipine-derivatives significant correlations were obtained mainly with steric parameters (Es, B1). The following example shows the regression analysis and the statistical data obtained with the new steric Verloop-parameter B1: log 1/ED50 =5.06 + 0,8 (± 0.15) · B1 n=8, r=0.91, T=5.28, F=27.88, P=0.0019


Angewandte Chemie | 1981

4-Aryldihydropyridines, a New Class of Highly Active Calcium Antagonists†

Friedrich Bossert; Horst Meyer; Egbert Wehinger


Archive | 1982

Method of combatting coronary and vascular diseases

Gerhard Franckowiak; Horst Boshagen; Friedrich Bossert; Siegfried Goldmann; Horst Meyer; Egbert Wehinger; Jurgen Stoltefuss; Matthias Schramm; Gunter Thomas; Robertson Towart


Angewandte Chemie | 1981

4‐Aryldihydropyridine, eine neue Klasse hochwirksamer Calcium‐Antagonisten

Friedrich Bossert; Horst Meyer; Egbert Wehinger


Archive | 1972

UNSYMMETRICAL ESTERS OF 1,4-DIHYDROPYRIDINE 3,5-DICARBOXYLIC ACID

Friedrich Bossert; Horst Meyer; Kurt Stoepel; Wulf Vater


Archive | 1982

Dihydropyridines with a positive inotropic activity, their use in pharmaceutical preparations, and processes for their preparation

Gerhard Dr. Franckowiak; Horst Boshagen; Friedrich Bossert; Siegfried Goldmann; Horst Meyer; Egbert Wehinger; Jürgen Dr. Stoltefuss; Matthias Schramm; Gunter Thomas; Robertson Towart


Archive | 1975

1,4-Dihydropyridine carboxylic acid esters

Friedrich Bossert; Horst Meyer; Wulf Vater


Archive | 1973

Pharmaceutical compositions containing unsymmetrical esters of 1,4-dihydropyridine 3,5-dicarboxylic acid

Horst Meyer; Friedrich Bossert; Wulf Vater; Kurt Stoepel


Archive | 1974

2-Amino-1,4-dihydropyridine derivatives

Horst Meyer; Friedrich Bossert; Wulf Vater; Kurt Stoepel

Collaboration


Dive into the Horst Meyer's collaboration.

Researchain Logo
Decentralizing Knowledge